might run back over 20 after meeting, page-35

Ok just got home.
Went to the meeting and took my wife along so she can see for herself why we have money in this company.
Half way through the meeting I asked her if we should sell (just to see her reaction) and she said no way.
Meeting was poorly attended with no more than 70 people which was a surprise.
I took down some quick notes.

* First animal trials with nano Tech for Ropren look promising.
* Bioeffectives sales team in AUstralia for bio A,B,I
* Independent director to be appointed.
* Dept of health want us producing 15kg (3000 courses) of Ropren before we can enter the market.
* 12 kg of Ropren made in November with 15kg likely to be made for Dec.
* Bio A deals done with Asia and Middle East finalised days ago.
* Charles not standing as director so room could be made for independent director.
Charles will be going to Russia to look after things there.
* Charles of to USA in March.

The directors are very very positive that this is a company that is going places and I still believe it.